What is the most common prevalence of sickle cell crises, including Painful Vaso-Occlusive Crisis (PVOC), acute chest syndrome, splenic sequestration, aplastic crises, and other complications in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Painful vaso-occlusive crisis (PVOC) is the most common complication of sickle cell disease in pediatric patients, accounting for approximately 60-80% of emergency visits, as supported by recent studies 1.

Common Complications of Sickle Cell Disease

The most prevalent complications of sickle cell disease in pediatric patients include:

  • Painful vaso-occlusive crisis (PVOC): characterized by severe pain in the extremities, back, chest, or abdomen due to microvascular occlusion from sickled red blood cells, affecting approximately 60-80% of patients 1.
  • Acute chest syndrome: occurring in about 15-20% of pediatric sickle cell patients, characterized by fever, chest pain, respiratory symptoms, and new pulmonary infiltrates 2.
  • Splenic sequestration: affecting approximately 10-30% of children, primarily those under 5 years, presenting with rapid splenic enlargement, acute anemia, and potential circulatory collapse 3.
  • Aplastic crisis: occurring in roughly 3-10% of patients, typically triggered by parvovirus B19 infection, resulting in severe anemia due to temporary cessation of red blood cell production 4.

Management and Prevention

Management of sickle cell disease focuses on:

  • Hydration
  • Pain control with appropriate analgesics
  • Oxygen therapy when needed
  • Transfusion therapy for severe cases Prevention strategies include:
  • Hydroxyurea therapy, which reduces crisis frequency by increasing fetal hemoglobin production 3
  • Regular comprehensive care
  • Prompt treatment of infections It is essential to note that the management of sickle cell disease should be individualized, and the use of a clinical pathway can improve the acute management of vaso-occlusive crisis pain in pediatric patients, as shown in a study published in 2014 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.